Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
non-small cell lung cancer treatment
market13 mentionslast seen Nov 9, 2026
Market for treatment of advanced stage 4 non-small cell lung cancer with significant unmet medical need.
Relationships 15
- ivonescimabapplies tonon-small cell lung cancer treatment99% confidence2 sources
- ENV-105applies tonon-small cell lung cancer treatment95% confidence1 source
- EIK1001applies tonon-small cell lung cancer treatment95% confidence1 source
- zipalertinibapplies tonon-small cell lung cancer treatment95% confidence1 source
- vopimetostatapplies tonon-small cell lung cancer treatment93% confidence1 source
- REQORSAapplies tonon-small cell lung cancer treatment92% confidence1 source
- Amtagviapplies tonon-small cell lung cancer treatment90% confidence1 source
- ATNM-400applies tonon-small cell lung cancer treatment90% confidence1 source
- The Lancet: Research in Contextapplies tonon-small cell lung cancer treatment85% confidence1 source
- CR-002applies tonon-small cell lung cancer treatment85% confidence1 source
- tumor infiltrating lymphocyte therapyapplies tonon-small cell lung cancer treatment85% confidence1 source
- CR-001applies tonon-small cell lung cancer treatment85% confidence1 source
- XmAb819applies tonon-small cell lung cancer treatment80% confidence1 source
- small molecule drug discoveryapplies tonon-small cell lung cancer treatment78% confidence1 source
- antibody-drug conjugateapplies tonon-small cell lung cancer treatment76% confidence1 source
Relationship
ivonescimabapplies tonon-small cell lung cancer treatment
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARSep 29, 2026Summit Therapeutics Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
HARMONi is a Phase III clinical trial evaluating ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC
- newsPR NewswireSep 18, 2026Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026
a U.S. patient with non-small cell lung cancer came to Jiahui to receive ivonescimab